Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21K Hold
58
0.02% 133
2026
Q1
$19K Hold
58
0.01% 133
2025
Q4
$19K Hold
58
0.01% 133
2025
Q3
$16.4K Sell
58
-16,136
-100% -$4.68M 0.01% 139
2025
Q2
$16.2M Buy
16,194
+16,136
+27,821% +$4.57M 0.01% 141
2025
Q1
$18.1K Hold
58
0.01% 135
2024
Q4
$15.1K Hold
58
0.01% 149
2024
Q3
$18.7K Hold
58
0.01% 147
2024
Q2
$18.1K Hold
58
0.01% 145
2024
Q1
$16.5K Hold
58
0.01% 151
2023
Q4
$16.7K Buy
+58
New +$15.8K 0.01% 152

Other funds holding AMGN

Broadwater Capital's AMGN Position: Q2 2026 in Review

Broadwater Capital held its Amgen (AMGN) position steady in Q2 2026 at 58 shares worth $21K. The position accounts for 0.02% of the portfolio, ranked #133.

Broadwater Capital first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $16.2M in Q2 2025. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Broadwater Capital held 58 shares of Amgen worth $21K as of Q2 2026.
  • Broadwater Capital left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.02% of Broadwater Capital's portfolio in Q2 2026, its #133 holding.
  • Broadwater Capital first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Broadwater Capital's Amgen position peaked at $16.2M in Q2 2025.
  • 1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Broadwater Capital's 13F filing for Q2 2026, filed 24 Jul 2026.